+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Public Health and Economic Impact of Vaccinating Children with a Quadrivalent live Attenuated Influenza Vaccine in France Using a Dynamic Transmission Model



Public Health and Economic Impact of Vaccinating Children with a Quadrivalent live Attenuated Influenza Vaccine in France Using a Dynamic Transmission Model



Value in Health 17(7): A674




(PDF emailed within 0-6 h: $19.90)

Accession: 058661224

Download citation: RISBibTeXText

PMID: 27202479

DOI: 10.1016/j.jval.2014.08.2502


Related references

Assessment of Public Health and Economic Impact of Intranasal Live-Attenuated Influenza Vaccination of Children in France Using a Dynamic Transmission Model. Applied Health Economics and Health Policy 15(2): 261-276, 2016

Public Health Outcomes of Paediatric Influenza Vaccination With An Intranasal Tetravalent Live Attenuated Vaccine In Belgium Using A Dynamic Transmission Model. Value in Health 18(7): A577, 2015

Uptake and impact of vaccinating primary school-age children against influenza: experiences of a live attenuated influenza vaccine programme, England, 2015/16. Euro Surveillance 23(25), 2018

The Health and Economic Impact of a Quadrivalent Human Papillomavirus Vaccine (6/11/16/18) in Columbia: A Transmission Dynamic Model-Based Evaluation. Value in Health 16(7): A713-A714, 2013

Public Health And Economic Impact of A Quadrivalent Influenza Vaccine In Comparison to The Trivalent Influenza Vaccine In Brazil Over The Period Of 2010 - 2013. Value in Health 18(7): A578-A579, 2015

Public health impact and economic benefits of quadrivalent influenza vaccine in Latin America. Human Vaccines and Immunotherapeutics 13(4): 877-888, 2017

Immunogenicity and safety of a quadrivalent live attenuated influenza vaccine in children. Pediatric Infectious Disease Journal 31(7): 745-751, 2012

Vaccinating high-risk children with the intranasal live-attenuated influenza vaccine: the Quebec experience. Paediatric Respiratory Reviews 15(4): 340-347, 2016

Immune Responses to Circulating and Vaccine Viral Strains in HIV-Infected and Uninfected Children and Youth Who Received the 2013/2014 Quadrivalent Live-Attenuated Influenza Vaccine. Frontiers in Immunology 7: 142, 2016

Estimated health and economic impact of quadrivalent HPV (types 6/11/16/18) vaccination in Brazil using a transmission dynamic model. Bmc Infectious Diseases 12: 250, 2013

Cost-Effectiveness analysis of Quadrivalent Versus trivalent Influenza Vaccination In Germany - Linking a Dynamic Transmission Model with Health and Economic Outcomes. Value in Health 18(7): A339, 2015

Estimates of the Public Health Impact of a Pediatric Vaccination Program Using an Intranasal Tetravalent Live-Attenuated Influenza Vaccine in Belgium. Paediatric Drugs 18(4): 303-318, 2016

The safety and efficacy of quadrivalent live attenuated influenza vaccine in Japanese children aged 2-18 years: Results of two phase 3 studies. Influenza and Other Respiratory Viruses 12(4): 438-445, 2018

Safety of Intranasal Quadrivalent Live Attenuated Influenza Vaccine (QLAIV) in Children and Adolescents: A Pilot Prospective Cohort Study in England. Drug Safety 39(4): 323-333, 2016

Impact of quadrivalent influenza vaccine on public health and influenza-related costs in Australia. Bmc Public Health 16: 630, 2017